Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF)

Journal of Clinical Investigation

Volumn 99, Issue 3, 1997, Pages 540-548

  Ye, Shaohua ^a   Nosrati, Said ^a   Campese, Vito M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

Chronic renal failure; Hypertension; Neurogenic factors; Nitric oxide

Indexed keywords

MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GENE EXPRESSION; HYPERTENSION; LOCUS CERULEUS; MALE; MEDULLA OBLONGATA; NEPHRECTOMY; NONHUMAN; NORADRENALIN BLOOD LEVEL; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0030752833     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119191     Document Type: Article

References (62)

1. Schalekamp, M.A.D.H., M.P.A. Schalekamp-Kuyken, M. de Moor-Fruytier, T. Meininger, D.J. Vaandrager-Kranenburg, and W.H. Birkenhager. 1973. Interrelationships between blood pressure, renin, renin substrate and blood volume in terminal renal failure. Clin. Sci. Mol. Med. 45:417-428.
2. Lazarus, J.M., C.L. Hampers, and J.P. Merrill. 1974. Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch. Intern. Med. 133:1059-1066.
3. Atuk, N.O., C.J. Bailey, S. Turner, M.J. Peach, and F.B. Westervelt, Jr. 1976. Red blood cell catechol-o-methyl transferase, plasma catecholamines and renin in renal failure. Trans. Am. Soc. Artif. Intern. Organs. 22:195-200.
4. Lake, C.R., M.G. Ziegler, M.D. Coleman, and I.J. Kopin. 1979. Plasma levels of norepinephrine and dopamine-beta-hydroxylase in CRF patients treated with dialysis. Cardiovasc. Med. 1:1099-1111.
5. Henrich, W.L., F.H. Katz, P.B. Molinoff, and R.W. Schrier. 1977. Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int. 12:279-284.
6. Izzo, J.L. Jr., M.S. Izzo, R.H. Sterns, and R.B. Freeman. 1982. Sympathetic nervous system hyperactivity in maintenance hemodialysis patients. Trans. Am. Soc. Artif. Intern. Organs. 28:604-607.
7. Cuche, J.L., J. Prinseau, F. Selz, G. Ruget, and A. Baglin. 1986. Plasma free, sulfo-and glucuro-conjugated catecholamines in uremic patients. Kidney Int. 30:566-572.
8. Yanagisawa, M., H. Kurihara, S. Kimura, T. Yoko, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.). 332:411-415.
9. Bigazzi, R., E. Kogosov, and V.M. Campese. 1994. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J. Am. Soc. Nephrol. 4:1901-1907.
10. Furchgott, R.F., J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.). 288:373-376.
11. Palmer, R.M., A.G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxation factor. Nature (Lond.). 327:524-526.
12. Amezcua, J.L., G.J. Dusting, R.M. Palmer, and S. Moncada. 1988. Acetylcholine induces vasodilation in the rabbit isolated heart through release of nitric oxide, the endogenous vasodilator. Br. J. Pharmacol. 95:830-834.
13. Palmer, R.M., D.S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond.). 333:664-666.
14. Ignarro, L.J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535-560.
15. Palmer, R.M.J., D.D. Rees, D.S. Ashron, and S. Moncada. 1988. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153:1251-1256.
16. Hu, L., R. Manning, Jr., and M.W. Brands. 1994. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 23:185-194.
17. Johnson, R.A., and R.H. Freeman. 1992. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production. Am. J. Hypertens. 5(part 1):919-922.
18. Ribiero, M.O., G. de Nucci, and R. Zatz. 1991. Persistant arterial hypertension by chronic blockade of nitric oxide synthesis. J. Am. Soc. Nephrol. 2: 512A.
19. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity. Circ. Res. 70:607-611.
20. 3H]dopa in various regions of the brain. J. Neurochem. 13:665-669.
21. Palkovits, M., and L. Zaborszky. 1977. Neuroanatomy of central cardiovascular control. In Hypertension and Brain Mechanisms, Progress in Brain Research. W. de Jong, A.P. Provoost and A.P. Shapiro, editors. Elsevier Science Publishing Co. Inc., Amsterdam. 9-34.
22. Peuler, J.D., and G.A. Johnson. 1977. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine, and dopamine. Life Sci. 21:625-636.
23. Yoshida, T., and G.A. Bray. 1984. Catecholamine turnover in rats with ventromedial hypothalamic lesions. Am. J. Physiol. 246:R558-R565.
24. Fisler, J.S., T. Yoshida, and G.A. Bray. 1984. Catecholamine turnover in S 5B/Pl and Osborne-Mendel rats: response to a high fat diet. Am. J. Physiol. 247:R290-R295.
25. Spector, S., A. Sjoerdsma, and S. Udenfriend. 1965. Blockade of endogenous norepinephrine synthesis by -methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 147:86-95.
26. Brodie, B.B., E. Costa, A. Dlabac, N.H. Neff, and H.H. Smookler. 1966. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154:493-498.
27. Taubin, H.L., B. Djahanguiri, and L. Landsberg. 1972. Noradrenaline concentration and turnover in different regions of the gastrointestinal tract of the rat: an approach to the evaluation of sympathetic activity in the gut. Gut. 13: 790-795.
28. Higuchi, R., and G. Dollinger. 1992. Simultaneous amplification and detection of specific DNA sequences. Biotechnology. 10:413-417.
29. Ye, S.H., and V.M. Campese. 1997. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. In press.
30. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun. 160:881-886.
31. Rees, D.D., R.M.J. Palmer, and S. Moncada. 1989. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA. 86:3375-3378.
32. Whittle, B.J., J. Lopez-Belmonte, and D.D. Rees. 1989. Modulation of the vasodepressor actions of acetylcholine, bardykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide. Br. J. Pharmacol. 98:646-652.
33. G-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA. 87:3629-3632.
34. Bredt, D.S., P.M. Hwang, and S.H. Snyder. 1990. Localization of nitric oxide synthase indicating a neuronal role for nitric oxide. Nature (Lond.). 347: 768-770.
35. Vincent, S.R., and H. Kimura. 1992. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:755-784.
36. Barinaga, M. 1991. Is nitric oxide the "retrograde messenger"? Science (Wash. DC). 254:1296-1297.
37. Togashi, H., I. Sakuma, M. Yoshioka, T. Kobayashi, H. Yasuda, A. Kitabatake, H. Saito, S.S. Gross, and R. Levi. 1992. A central nervous system action of nitric oxide in blood pressure regulation. J. Pharmacol. Exp. Ther. 262: 343-347.
38. Shapoval, L.N., V.F. Sagach, and L.S. Pobegailo. 1991. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci. Lett. 132:47-50.
39. Harada, S., S. Tokunaga, M. Momohara, H. Masaki, T. Tagawa, T. Imaizumi, and A. Takeshita. 1993. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ. Res. 72:511-516.
40. Toda, N., Y. Kitamura, and T. Okamura. 1993. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension. 21:3-8.
41. Campese, V.M., and E. Kogosov. 1995. Renal afferent denervation prevents hypertensin in rats with chronic renal failure. Hypertension. 25:878-882.
42. Enoch, D.M., and F.W.L. Kerr. 1967. Hypothalamic vasopressor and vesicopressor pathways. Arch. Neurol. 16:290-306.
43. Takeda, K., and R.D. Bunag. 1978. Sympathetic hyperactivity during hypothalamic stimulation in spontaneously hypertensive rats. J. Clin. Invest. 62: 642-648.
44. Juskevich, J.C., D.S. Robinson, and D. Whitehorn. 1978. Effect of hypothalamic stimulation in spontaneously hypertensive and Wistar-Kyoto Rats. Eur. J. Pharmacol. 51:429-439.
45. Ward, D.G., and C.G. Gunn. 1976. Locus coeruleus complex: elicitation of a pressor response and a brain stem region necessary for its occurrence. Brain Res. 107:401-406.
46. Sakaguchi, T., M. Takahashi, and G.A. Bray. 1988. Lateral hypothalamus and sympathetic firing rate. Am. J. Physiol. 255:R507-R512.
47. Ciriello, J., and F.R. Calaresu. 1980. Role of paraventricular and supraoptic nuclei in central cardiovascular regulation in the cat. Am. J. Physiol. 239:R137-R142.
48. Converse, R.L., Jr, T.N. Jacobsen, R.D. Toto, C.M. Jost, F. Cosentino, F. Fouad-Tarazi, and R.G. Victor. 1992. Sympathetic overactivity in patients with CRF. N. Engl. J. Med. 327:1912-1918.
49. Vallance, P., A. Leone, A. Calver, J. Collier, and S. Moncada. 1992. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 339:572-575.
50. Noris, M., A. Benigni, P. Boccardo, S. Aiello, F. Gaspari, M. Todeschini, M. Figliuzzi, and G. Remuzzi. 1993. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int. 44: 445-450.
51. Remuzzi, G., N. Perico, C. Zoja, D. Corna, D. Macconi, and G. Vigano. 1990. Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J. Clin. Invest. 86:1768-1771.
52. Patel, K.P., and R.L. Kline. 1984. Influence of renal nerves on noradrenergic responses to changes in arterial pressure. Am. J. Physiol. 247:R615-R620.
53. Chalmers, J.P. 1975. Brain amines and models of experimental hypertension. Circ. Res. 36:469-480.
54. Bunag, R.D., and A.E. Eferakeya. 1976. Immediate hypotensive after-effects of posterior hypothalamic lesions in awake rats with spontaneous, renal, or DOCA hypertension. Cardiovasc. Res. 10:663-671.
55. Nakata, T., W. Berard, E. Kogosov, and N. Alexander. 1990. Microdialysis in the posterior hypothalamus: sodium chloride affects norepinephrine release, mean arterial pressure, heart rate and behavior in awake rats. Brain Res. Bull. 25:593-598.
56. Granata, A.R., D.A. Ruggiero, D.H. Park, T.H. Joh, and D.J. Reis. 1985. Brain stem area with C1 epinephrine neurons mediates baroreflex vasodepressor responses. Am. J. Physiol. 248:H547-H567.
57. Kalia, M., K. Fuxe, and M. Goldstein. 1985. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J. Comp. Neurol. 233:308-332.
58. Armstrong, D.M., C.A. Ross, V.M. Pickel, T.H. Joh, and D.J. Reis. 1982. Distribution of dopamine-, noradrenaline-, and adrenaline-containing cell bodies in the rat medulla oblongata: demonstrated by the immunocytochemical localization of catecholamine biosynthetic enzymes. J. Comp. Neurol. 212:173-187.
59. Howe, P.R., M. Costa, J.B. Furness, and J.P. Chalmers. 1980. Simultaneous demonstration of phenylethanolamine N-methyltransferase immunofluorescent and catecholamine fluorescent nerve cell bodies in the rat medulla oblongata. Neuroscience. 5:2229-2238.
60. Ruggiero, D.A., P.J. Gatti, R.A. Gillis, W.P. Normon, M. Anwar, and D.J. Reis. 1986. Adrenaline-synthesizing neurons in the medulla of the cat. J. Comp. Neurol. 252:532-542.
61. Chalmers, J., and P. Pilowsky. 1991. Brainstem and bulbospinal neuratransmitter systems in the control of blood pressure. J. Hypertens. 9:675-694.
62. Zanzinger, J., J. Czachurski, and H. Seller. 1995. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am. J. Physiol. 268:R958-R962.